{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:41:36Z","timestamp":1791726096210,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08602-1","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:40:39Z","timestamp":1751420439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single cell RNA sequencing to identify an Immunogenic cell death related prognostic signature in intrahepatic cholangiocarcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Bowen","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"8602_CR1","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/2159-8290.CD-17-0245","volume":"7","author":"JW Valle","year":"2017","unstructured":"Valle, J. W., Lamarca, A., Goyal, L., Barriuso, J. & Zhu, A. X. New horizons for precision medicine in biliary tract cancers. Cancer Discov. 7, 943\u2013962 (2017).","journal-title":"Cancer Discov"},{"key":"8602_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley, R. K., Bridgewater, J., Gores, G. J. & Zhu, A. X. Systemic therapies for intrahepatic cholangiocarcinoma. J. Hepatol. 72, 353\u2013363 (2020).","journal-title":"J. Hepatol."},{"key":"8602_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21037\/hbsn.2017.01.02","volume":"6","author":"A Gupta","year":"2017","unstructured":"Gupta, A. & Dixon, E. Epidemiology and risk factors: Intrahepatic cholangiocarcinoma. Hepatobil. Surg. Nutr. 6, 101\u2013104 (2017).","journal-title":"Hepatobil Surg. Nutr."},{"key":"8602_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","volume":"6","author":"RD Kim","year":"2020","unstructured":"Kim, R. D. et al. A phase 2 Multi-Institutional study of nivolumab for patients with advanced refractory biliary tract Cancer. JAMA Oncol. 6, 888\u2013894 (2020).","journal-title":"JAMA Oncol."},{"key":"8602_CR5","doi-asserted-by":"publisher","first-page":"167276","DOI":"10.1016\/j.bbadis.2024.167276","volume":"1870","author":"Y Liang","year":"2024","unstructured":"Liang, Y. et al. Single-Cell analysis reveals Hypoxia-Induced immunosuppressive microenvironment in intrahepatic cholangiocarcinoma. Biochim. Biophys. Acta-Mol. Basis Dis. 1870, 167276 (2024).","journal-title":"Biochim. Biophys. Acta-Mol Basis Dis."},{"key":"8602_CR6","doi-asserted-by":"crossref","unstructured":"Galluzzi, L. et al. Consensus guidelines for the definition, detection and interpretation of Immunogenic cell death. J. Immunother. Cancer 8, (2020).","DOI":"10.1136\/jitc-2019-000337corr1"},{"key":"8602_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nrc3380","volume":"12","author":"DV Krysko","year":"2012","unstructured":"Krysko, D. V. et al. Immunogenic cell death and damps in Cancer therapy. Nat. Rev. Cancer. 12, 860\u2013875 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"8602_CR8","doi-asserted-by":"crossref","unstructured":"Wang, H. et al. POSTN(+) Cancer-Associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma. J. Immunother. Cancer 12, (2024).","DOI":"10.1136\/jitc-2023-008721"},{"key":"8602_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","volume":"17","author":"N Yatim","year":"2017","unstructured":"Yatim, N., Cullen, S. & Albert, M. L. Dying cells actively regulate adaptive immune responses. Nat. Rev. Immunol. 17, 262\u2013275 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"8602_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","volume":"20","author":"T Gong","year":"2020","unstructured":"Gong, T., Liu, L., Jiang, W. & Zhou, R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol. 20, 95\u2013112 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"8602_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm1523","volume":"13","author":"M Obeid","year":"2007","unstructured":"Obeid, M. et al. Calreticulin exposure dictates the immunogenicity of Cancer cell death. Nat. Med. 13, 54\u201361 (2007).","journal-title":"Nat. Med."},{"key":"8602_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi, E., Satija, R. & Single-Cell, R. N. A. Sequencing to explore immune cell heterogeneity. Nat. Rev. Immunol. 18, 35\u201345 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"8602_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12885-016-2545-1","volume":"16","author":"I Snapkov","year":"2016","unstructured":"Snapkov, I. et al. The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis. BMC Cancer. 16, 490 (2016).","journal-title":"BMC Cancer"},{"key":"8602_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11060-007-9443-y","volume":"86","author":"XH Yao","year":"2008","unstructured":"Yao, X. H. et al. Production of angiogenic factors by human glioblastoma cells following activation of the G-Protein coupled formylpeptide receptor FPR. J. Neurooncol. 86, 47\u201353 (2008).","journal-title":"J. Neurooncol"},{"key":"8602_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang, M. et al. Role of tumor microenvironment in tumorigenesis. J. Cancer. 8, 761\u2013773 (2017).","journal-title":"J. Cancer"},{"key":"8602_CR16","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/ijc.34716","volume":"154","author":"A Kida","year":"2024","unstructured":"Kida, A. et al. Effects of adoptive T-Cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinoma. Int. J. Cancer. 154, 738\u2013747 (2024).","journal-title":"Int. J. Cancer"},{"key":"8602_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41577-018-0117-0","volume":"19","author":"SR Paludan","year":"2019","unstructured":"Paludan, S. R., Reinert, L. S. & Hornung, V. DNA-Stimulated cell death: Implications for host defence, inflammatory diseases and Cancer. Nat. Rev. Immunol. 19, 141\u2013153 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"8602_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-023-04449-6","volume":"165","author":"C Hou","year":"2023","unstructured":"Hou, C. et al. Targeting TNFAIP2 induces Immunogenic cell death and sensitizes glioblastoma multiforme to Anti-PD-1 therapy. J. Neurooncol. 165, 79\u201390 (2023).","journal-title":"J. Neurooncol"},{"key":"8602_CR19","doi-asserted-by":"publisher","first-page":"29189","DOI":"10.1021\/jacs.4c11636","volume":"146","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. PAMAM-Based polymeric Immunogenic cell death inducer to potentiate Cancer immunotherapy. J. Am. Chem. Soc. 146, 29189\u201329198 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"8602_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris, D. et al. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J. Clin. 73, 198\u2013222 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"8602_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken, K. E. & Wherry, E. J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265\u2013276 (2015).","journal-title":"Trends Immunol."},{"key":"8602_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"8602_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395\u2013412 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"8602_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson, D. E., O\u2019Keefe, R. A. & Grandis, J. R. Targeting the IL-6\/JAK\/STAT3 signalling Axis in Cancer. Nat. Rev. Clin. Oncol. 15, 234\u2013248 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8602_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1096\/fj.06-7464rev","volume":"21","author":"LH Lim","year":"2007","unstructured":"Lim, L. H. & Pervaiz, S. Annexin 1: The new face of an old molecule. Faseb J. 21, 968\u2013975 (2007).","journal-title":"Faseb J."},{"key":"8602_CR26","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1126\/science.aad9024","volume":"351","author":"D Hnisz","year":"2016","unstructured":"Hnisz, D. et al. Activation of Proto-Oncogenes by disruption of chromosome neighborhoods. Science 351, 1454\u20131458 (2016).","journal-title":"Science"},{"key":"8602_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1289\/ehp.929813","volume":"98","author":"MW Anderson","year":"1992","unstructured":"Anderson, M. W., Reynolds, S. H., You, M. & Maronpot, R. M. Role of Proto-Oncogene activation in carcinogenesis. Environ. Health Perspect. 98, 13\u201324 (1992).","journal-title":"Environ. Health Perspect."},{"key":"8602_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12032-014-0327-7","volume":"31","author":"Y Lin","year":"2014","unstructured":"Lin, Y., Lin, G., Fang, W., Zhu, H. & Chu, K. Increased expression of Annexin a1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med. Oncol. 31, 327 (2014).","journal-title":"Med. Oncol."},{"key":"8602_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1620\/tjem.222.243","volume":"222","author":"N Su","year":"2010","unstructured":"Su, N. et al. Increased expression of Annexin a1 is correlated with K-Ras mutation in colorectal Cancer. Tohoku J. Exp. Med. 222, 243\u2013250 (2010).","journal-title":"Tohoku J. Exp. Med."},{"key":"8602_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-21-3114","volume":"28","author":"PL Triozzi","year":"2022","unstructured":"Triozzi, P. L. et al. Circulating immune bioenergetic, metabolic, and genetic signatures predict melanoma patients\u2019 response to Anti-PD-1 immune checkpoint Blockade. Clin. Cancer Res. 28, 1192\u20131202 (2022).","journal-title":"Clin. Cancer Res."},{"key":"8602_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"8602_CR32","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for Taxonomy-Based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08602-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08602-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08602-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:40:40Z","timestamp":1751420440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08602-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08602-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5371445\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23501"}}